Windlas Biotech informs about outcome of board meeting

12 Nov 2024 Evaluate

Windlas Biotech has informed that the Board of Directors at its Meeting held on Tuesday, November 12, 2024, approved the Un-audited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2024. In this regard it has enclosed the following: i. Un-audited Standalone and Consolidated Financial Results for the Quarter and Half Year ended September 30, 2024. ii. Limited Review Report of the Auditors on Standalone and Consolidated Financial Results for the Quarter and Half Year ended September 30, 2024. The meeting of the Board of Directors commenced at 12.20 pm and concluded at 1.45 pm.

The above information is a part of company’s filings submitted to BSE.

Windlas Biotech Share Price

1031.75 5.35 (0.52%)
20-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.50
Dr. Reddys Lab 1342.45
Cipla 1472.45
Lupin 2147.55
Zydus Lifesciences 973.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.